NCT02991131View on ClinicalTrials.gov

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study

TerminatedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

December 17, 2016

Primary Completion Date

November 21, 2018

Study Completion Date

November 21, 2018

Conditions
Skin Disease, Infectious
Interventions
DRUG

Tedizolid (Sivextro, BAY1192631)

Antibiotic

DRUG

Linezolid

Antibiotic

Trial Locations (3)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY